What are the symptoms and treatment of peritonitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peritonitis: Symptoms and Treatment

Clinical Symptoms

Peritonitis presents with abdominal pain and tenderness in 74-95% of patients, typically accompanied by rebound tenderness and guarding, with abdominal rigidity being the most specific finding that strongly suggests peritoneal inflammation. 1, 2

Cardinal Symptoms

  • Abdominal pain and tenderness with rebound tenderness and guarding (74-95% of cases) 1, 2
  • Abdominal rigidity - the most specific physical finding 2
  • Fever greater than 38.5°C (38% of patients) 1, 2
  • Nausea and vomiting (35% of patients) 2
  • Abdominal distension with decreased bowel sounds 1, 2

Vital Sign Changes

  • Tachycardia (62.5% of patients) - NOT bradycardia 1, 2
  • Hypotension indicating progression to septic shock 2
  • Tachypnea as part of systemic inflammatory response 2

Laboratory Abnormalities

  • Leukocytosis with left shift (band neutrophils >20%) 1, 2
  • Elevated C-reactive protein 1, 2
  • Increased serum creatinine (>50% above baseline) 1, 2
  • Elevated serum lactate indicating tissue hypoperfusion 1, 2

Ascitic Fluid Findings (When Present)

  • Polymorphonuclear leukocyte (PMN) count >250/mm³ is diagnostic for spontaneous bacterial peritonitis 3
  • Low glucose (<50 mg/dL) suggests secondary peritonitis 3, 1
  • Elevated LDH and high total protein (≥1 g/dL) suggest secondary peritonitis 3

Distinguishing Primary vs. Secondary Peritonitis

Primary (Spontaneous) Bacterial Peritonitis

  • Occurs in cirrhotic patients with ascites without gastrointestinal perforation 1
  • Single organism on culture 1
  • PMN count >250/mm³ in ascitic fluid 3

Secondary Peritonitis

Secondary peritonitis should be suspected when multiple organisms are cultured, ascitic PMN count exceeds 1,000/mm³, or when imaging shows free air or bowel perforation. 3, 1

Key differentiating features include:

  • Multiple organisms on Gram stain or culture 3
  • PMN count >1,000/mm³ 3
  • Ascitic glucose <50 mg/dL 3, 1
  • Ascitic LDH above normal serum upper limit 3
  • Elevated CEA (>5 ng/mL) or alkaline phosphatase (>240 U/L) 3
  • Failure of PMN count to decrease after 48 hours of antibiotics 3

Treatment Approach

Spontaneous Bacterial Peritonitis

For suspected spontaneous bacterial peritonitis, initiate empirical therapy with intravenous cefotaxime 2 g every 8 hours or ceftriaxone 1 g every 12-24 hours immediately, even before culture results are available. 3

Antibiotic Therapy

  • Cefotaxime 2 g IV every 8 hours (first-line, resolution rate 69-98%) 3
  • Ceftriaxone 1 g IV every 12-24 hours (alternative, resolution rate 73-100%) 3
  • Treatment duration: 5-10 days depending on clinical response 3
  • Oral ofloxacin 400 mg twice daily may substitute for IV therapy in stable patients without prior quinolone exposure, vomiting, shock, or grade II hepatic encephalopathy 3

Albumin Administration

  • Albumin infusion reduces renal failure and mortality in SBP patients 1

Indications to Treat

  • PMN count >250/mm³ regardless of symptoms 3
  • PMN count <250/mm³ WITH fever >37.8°C (100°F), abdominal pain, or tenderness - treat empirically while awaiting cultures 3

Secondary Peritonitis

Secondary peritonitis requires both surgical source control and broad-spectrum antibiotics covering aerobic, anaerobic, and potentially resistant organisms. 1, 4

Source Control (Essential)

  • Immediate surgical intervention for perforation or abscess 1, 5
  • Damage control surgery in life-threatening situations 4
  • Drainage, debridement, and abdominal cleansing 1, 4
  • CT imaging to identify perforation or abscess when diagnosis uncertain 3, 1

Antibiotic Coverage

For community-acquired secondary peritonitis, use meropenem 1 g IV every 8 hours, which covers the causative organisms including E. coli, Klebsiella, Pseudomonas, Bacteroides fragilis, and Peptostreptococcus species. 6

Alternative regimens based on severity:

  • Moderate cases: Cefoxitin, amoxicillin-clavulanate + gentamicin, or piperacillin-tazobactam 7
  • Severe/nosocomial cases: Imipenem + amikacin 7
  • Add anaerobic coverage (already included in above regimens) 3, 7
  • Consider antifungal therapy (fluconazole) in nosocomial/tertiary peritonitis until cultures available 7, 4

Duration

  • 48 hours to 14 days depending on severity and clinical response 7

Critical Pitfalls to Avoid

  • Do NOT delay antibiotics - mortality increases significantly with treatment delay 1, 4
  • Do NOT perform unnecessary laparotomy in cirrhotic patients with SBP - differentiate from secondary peritonitis first 3
  • Do NOT assume bradycardia - tachycardia is the expected finding 1, 2
  • Do NOT miss secondary peritonitis - if PMN count doesn't decrease after 48 hours of antibiotics or if multiple organisms are present, pursue imaging and surgical consultation 3
  • Do NOT forget renal dosing - adjust antibiotics for creatinine clearance <50 mL/min 6

Monitoring and Follow-up

  • Repeat paracentesis is NOT routinely needed in typical SBP with good clinical response 3
  • Repeat paracentesis IS indicated when setting, symptoms, organisms, or response are atypical 3
  • Monitor for complications: renal failure, hepatic encephalopathy, septic shock, and multi-organ failure 1, 2

References

Guideline

Peritonitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clinical Presentation and Complications of Peritonitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of secondary peritonitis.

Annals of surgery, 1996

Research

[Therapeutic management of peritonitis].

Medecine et maladies infectieuses, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.